Ask About Adherence is a blog series featuring discussions with experts and new medication adherence resources. In this post, Sloane Salzburg, M.S, executive director of Prescriptions for a Healthy America, discusses a recent meeting on the importance of medication adherence in which stakeholders agreed on four priorities.
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
In efforts to move toward a healthcare system that is more based on value, a key driver of rising costs is often missing: medication non-adherence. Improving adherence to prescribed medicines can allow the system to reign in rising health costs while simultaneously improving patient care, quality, and outcomes.
Studies have shown that people who don’t take their medicines are more likely to end up back in the hospital or in the emergency room than those who do —leading to avoidable annual healthcare costs totaling up to $300 billion.
What can we do? Prescriptions for a Healthy America and Duke University’s Medication Adherence Alliance assembled a diverse group of experts from Washington, D.C., California, North Carolina and many places in between, representing patients, physicians, pharmacists, pharmaceuticals and other life science organizations. Together, we coalesced around four priorities for fixing this problem:
For more information, check out an op-ed coauthored by Salzburg and Hayden Bosworth, professor at Duke University Medical Center, in Forbes here.